Agios Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,455	1,352	1,810	1,126	1,444	1,570
Market Cap Growth	-22.71%	-25.31%	60.74%	-22.00%	-8.03%	-36.02%
Enterprise Value	500	319	265	405	568	429
Last Close Price	24.20	23.00	31.60	20.40	25.40	29.62
PE Ratio	-	-	2.78	-	-	1.11
PS Ratio	31.61	29.38	51.35	46.40	108.35	-
PB Ratio	1.43	1.33	1.22	1.54	1.40	1.38
P/TBV Ratio	1.43	1.33	1.22	1.54	1.40	1.38
EV/Sales Ratio	10.91	6.93	7.51	16.70	42.61	-
EV/FCF Ratio	-1.56	-	-	-	-	-
Debt / Equity Ratio	0.03	0.03	0.04	0.09	0.08	0.08
Net Debt / Equity Ratio	-0.94	-0.94	-0.96	-0.90	-0.92	-0.92
Net Debt / EBITDA Ratio	2.41	2.41	3.51	1.91	2.66	3.22
Net Debt / FCF Ratio	2.98	2.98	3.77	2.47	3.22	2.88
Asset Turnover	0.04	0.04	0.03	0.03	0.01	-
Inventory Turnover	11.43	11.43	13.08	21.65	-	-
Quick Ratio	10.53	10.53	11.06	11.49	12.54	17.17
Current Ratio	11.46	11.46	11.90	12.27	13.30	17.79
Return on Equity (ROE)	-30.20%	-30.20%	57.29%	-36.83%	-19.38%	-42.15%
Return on Assets (ROA)	-19.93%	-19.93%	-20.47%	-22.49%	-18.17%	-20.65%
Return on Invested Capital (ROIC)	-125.09%	-87.18%	-98.60%	-153.69%	-100.74%	-251.59%
Return on Capital Employed (ROCE)	-38.90%	-38.90%	-26.90%	-45.00%	-33.10%	-27.50%
Earnings Yield	-24.17%	-26.00%	35.95%	-28.29%	-15.02%	89.89%
FCF Yield	-22.09%	-23.77%	-20.89%	-23.87%	-20.38%	-23.14%
Buyback Yield / Dilution	-0.14%	-0.14%	-4.02%	-1.57%	9.36%	12.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.